Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

14.89
Delayed Data
As of Mar 24
 +0.05 / +0.34%
Today’s Change
12.25
Today|||52-Week Range
27.02
-17.37%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues104.8M116.7M110.5M123.9M
 
 
 
 
 
Cost of Goods Sold19.9M20.3M19.6M22.0M
 
 
 
 
 
Depreciation And Amortization27.7M27.7M27.7M26.4M
 
 
 
 
 
 
Operating ExpensesGross Income57.2M68.7M63.2M75.5M
 
 
 
 
 
General Expenses58.7M59.1M61.9M57.6M
 
 
 
 
 
Research And Development5.9M7.1M10.4M9.2M
 
 
 
 
 
Total Operating Expenses106.3M107.1M109.2M106.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.5M9.6M1.3M17.9M
 
 
 
 
 
Extraordinary Credit177.0K110.0K0.000.00
 
 
 
Extraordinary Charge-3.6M-6.4M-686.0K0.00
 
 
 
 
Interest Expense On Debt22.1M19.5M19.7M20.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-26.9M-16.2M-18.9M-2.5M
 
 
 
 
 
Income Taxes-6.0M-5.7M-6.0M-41.9M
 
 
 
 
 
Net Income-20.9M-10.5M-12.9M-44.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS60.9M61.2M61.4M61.7M
 
 
 
 
 
Shares To Calculate EPS Diluted60.9M61.2M61.4M61.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.34-$0.17-$0.21-$0.72
 
 
 
 
 
EPS Diluted-$0.34-$0.17-$0.21-$0.72